27 studies on Hexarelin curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
Independent certificate-of-analysis evidence from third-party labs — the data behind the studies. Updated as new COAs are verified. Read the full grey-market analysis →
| Manufacturer | Batches | Avg purity | |
|---|---|---|---|
| Transforma Peptides | 2 | 99.39% | View COA → |
| Peptide Powerhouse | 2 | 99.39% | View COA → |
| Qingdao Sigma Chemical | 2 | 99.32% | View COA → |
Recent certificates: #11995 (99.54%) · #14854 (99.545%) · #19292 (99.053%) · #19294 (99.736%) · #19362 (99.053%) · #19363 (99.736%)
Manufacturers with published third-party certificates of analysis for Hexarelin. Open a vendor to see every batch we've verified.
This research provides crucial insights into how major public health crises can influence substance use behaviors, particularly concerning PIEDs. The observed shift towards online procurement and mental health-driven …
This review underscores that zebrafish models provide a cost-effective and high-throughput alternative to traditional mammalian models for early-stage drug discovery and toxicology screening. Their ability to rapidly …
The discovery and characterization of GHS-R3a significantly expands our understanding of the ghrelin system's complexity and evolution in vertebrates. This novel receptor provides new insights into the intricate mecha…
This study provides compelling evidence for hexarelin's potential as a novel therapeutic agent for ischemic heart failure by beneficially modulating the PTEN/Akt/ERK signaling pathway. The observed significant improve…
This research highlights Hexarelin's potential as a therapeutic agent for preventing or treating cardiac hypertrophy, a significant contributor to heart failure and a major public health concern. By demonstrating its …
This research offers a crucial breakthrough in the quest for oral peptide drug delivery, potentially revolutionizing how many chronic conditions are treated. By identifying effective strategies to boost intestinal per…
This research provides compelling evidence that Hexarelin possesses significant anti-atherosclerotic properties by directly interfering with a crucial mechanism of plaque formation: macrophage ox-LDL uptake. Targeting…
This research highlights Hexarelin's potential as a novel therapeutic agent for mitigating the severe damage caused by myocardial ischemia-reperfusion injury. By simultaneously preserving cardiac function and dampenin…
This research highlights a promising therapeutic avenue for obesity and related metabolic disorders by leveraging the body's own growth hormone system. Activating the GHSR could offer a strategy to improve body compos…
This research highlights Hexarelin's significant neuroprotective potential against oxidative stress, a fundamental process implicated in numerous neurodegenerative conditions. By elucidating its mechanism through the …
This research provides compelling evidence that paracellular permeation enhancers can dramatically improve the oral absorption of peptide drugs, potentially paving the way for non-injectable formulations. The substant…
This research highlights Hexarelin's potential as a novel therapeutic agent for abdominal aortic aneurysm (AAA), a life-threatening condition with limited pharmacological treatments. By simultaneously addressing both …
This study provides compelling evidence, supported by cutting-edge imaging, that Hexarelin effectively mitigates cardiac damage and improves heart function after a myocardial infarction. The detailed microstructural i…
This research highlights the significant neuroprotective potential of ghrelin receptor agonists, such as Hexarelin and JMV2894, in mitigating the cellular damage associated with the SOD1-G93A mutation, a key driver of…
This research highlights Hexarelin's potential as a potent neuroprotective agent for conditions involving retinal ganglion cell (RGC) loss. Given the devastating impact of optic neuropathies on vision, finding compoun…
The potent growth hormone-releasing and direct tissue-protective properties of Hexarelin highlight its significant therapeutic potential. Its ability to stimulate GH release could be beneficial for conditions characte…
This research highlights a novel role for the ghrelin receptor system in modulating opioid tolerance, suggesting that targeting these receptors could offer a new therapeutic strategy. Attenuating morphine tolerance co…
This comprehensive review underscores the broad therapeutic potential of GHS across multiple organ systems and conditions. The observed benefits, from cardioprotection and growth promotion to metabolic improvements an…
This review critically highlights the therapeutic potential of GHRPs beyond their established GH-releasing properties, suggesting they could be novel pharmacological agents for treating various cardiovascular diseases…
This research is significant because it highlights the complex interplay between hexarelin and different cardiac cell types, specifically emphasizing the often-overlooked role of endothelial cells in mediating drug ef…
This research highlights a novel and potentially significant role for synthetic peptidyl GH secretagogues beyond their traditional endocrine functions, suggesting they could be repurposed as direct anticancer agents. …
This advanced analytical method significantly enhances anti-doping efforts by providing a highly sensitive, robust, and expandable tool for detecting a broad panel of small prohibited peptides. The ability to detect t…
This advanced analytical method provides a crucial tool for anti-doping agencies to combat the illicit use of GHRPs in both equine and human sports. By enabling reliable and high-throughput detection, it helps ensure …
This research significantly enhances anti-doping capabilities by providing specific, long-lasting biomarkers for GHRPs administered nasally. The identification of these metabolites means that athletes misusing these s…
Free, no account — handy when you're working with Hexarelin.